4//SEC Filing
Robbins Andrew R 4
Accession 0001209191-20-055909
CIK 0001622229other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:05 PM ET
Size
5.7 KB
Accession
0001209191-20-055909
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-10-23+7,442,421→ 7,442,421 totalExercise: $2.79Exp: 2030-10-22→ Common Stock (7,442,421 underlying)
Footnotes (1)
- [F1]This stock option shall vest as follows: 25% on the first anniversary of the date of grant; then in equal monthly installments over 36 months.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 4:05 PM ET
- Size
- 5.7 KB